Skip to main content
Premium Trial:

Request an Annual Quote

Christiane Honisch

Pathoquest announced today that it has appointed Christiane Honisch as an independent member of the firm's board of directors. With over 15 years of experience developing markers, assays, software, and technology for infectious disease detection, Honisch is currently head of global business intelligence and development at Eppendorf. Prior to Eppendorf, Honisch served as director of microbiology markets at Illumina. Before working at Illumina, Honisch served as director of infectious disease research at Roche Molecular Diagnostics.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.